Cargando…
Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
Autores principales: | Uro-Coste, Charlotte, Atenza, Alba, Heng, Anne-Elisabeth, Rouzaire, Paul-Olivier, Garrouste, Cyril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411423/ https://www.ncbi.nlm.nih.gov/pubmed/36033643 http://dx.doi.org/10.3389/ti.2022.10681 |
Ejemplares similares
-
Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score Analysis
por: Noelle, Juliette, et al.
Publicado: (2023) -
Management and Outcome After Early Renal Transplant Vein Thrombosis: A French Multicentre Observational Study of Real-Life Practice Over 24 Years
por: Cambou, Ludivine, et al.
Publicado: (2023) -
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023) -
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy
por: Morel, Antoine, et al.
Publicado: (2022) -
Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
por: Morath, Christian, et al.
Publicado: (2022)